Illumina said on Tuesday that it has partnered with French company GenoScreen on genomic testing for multidrug-resistant tuberculosis.

On October 15, the General Office of Hangzhou Municipal People's Government issued the "Notice on Several Measures to Accelerate the High-Quality Development of Biomedical Industry"

Biodesix said Monday that it has been awarded a US Federal Supply Schedule contract for cancer testing of covered patients served by the Veterans Health Administration and Military Health System.

PBD Biotech said Monday it gained investment funding of ￡2.4 million ($2.7 million) to support clinical trials for its Actiphage rapid screening test for latent tuberculosis infections and their potential to develop into serious disease.

Since October, companies in the pharmaceutical field have successively announced monthly forecasts for the first three quarters.

Canadian diagnostics firm MedMira said on Friday that its Vyra COVID-19 Antigen Test has been CE marked and is now available in countries that accept the designation.

National Health Service England on Wednesday published a five-year strategy on accelerating the adoption of genomics into the British healthcare system. The new strategy places genomics at the heart of a new effort to deliver a sustainable model of healthcare for patients.

On October 13, 2022, the Shenzhen Stock Exchange disclosed that the 73rd Review Meeting of the GEM Listing Committee in 2022 was held and approved Jiaxing Quaero Life Science Co., Ltd. to be listed on the Sci-Tech Innovation Board.

Standard BioTools — formerly Fluidigm — said on Thursday that its Biomark and Juno molecular diagnostic systems have received approval from China's National Medical Products Administration.

GE published a regulatory filing about the spinoff of its healthcare unit, which it expects to complete in the first week of 2023, if the transaction is approved by its board of directors. GE HealthCare will be listed on the Nasdaq under the ticker “GEHC.”

QuidelOrtho on Wednesday reported preliminary third quarter revenues of between $782 million and $785 million.

Illumina said on Tuesday that it has entered into a strategic research collaboration with AstraZeneca on drug target discovery.

Amoy (300685.SZ) and Beigene (NASDAQ: BGNE, HKEX: 06160, SSE: 688235) have recently entered into a strategic collaboration on companion diagnostics.

Beckman Coulter Diagnostics said Tuesday that it has acquired StoCastic, a startup informatics company that develops artificial intelligence-based clinical decision support for hospital emergency departments. Financial terms were not disclosed.

Wall Street had a mixed reaction to a report that Bio-Rad Laboratories and Qiagen are in talks about a possible merger.

September 21, Merck, a leading global technology company, announced the opening of the first phase of its EUR 29 million biosafety testing laboratory in China, a virus clearance validation laboratory. The 5,000 square meter center is Merck's first laboratory of its kind in China.

Cytiva, backed by a $1.5 billion investment from its parent company, the Danaher Group, continued its expansion tear with the acquisition of CEVEC Pharmaceuticals.

Thermo Fisher Scientific said on Monday that it has received CE-IVD marking for its TaqPath Enteric Bacterial Select Panel, a PCR-based assay developed to detect common gastrointestinal (GI) bacteria.

Before the Chinese National Day holiday, NINGBO SCIENTZ Biotechnology announced that the company will be listed on the Beijing Stock Exchange on October 10, 2022. The issue price of NINGBO SCIENTZ Biotechnology is 15 CNY per share, and the issue price-earnings ratio is 30.12 times.

The US Food and Drug Administration said Friday it has granted Emergency Use Authorization for Abbott's real-time PCR monkeypox test, the Alinity m MPXV assay.